The clinical presentation of patients harbouring MAPT pathogenic variants is heterogeneous even within the same family; bvFTD, nfvPPA, PSP, and CBS are all described, whereas symptoms of MND are rare [73,74,94,95]. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.